Gian Marco Leali

Title: Inventor Gian Marco Leali: Innovations in Phthalazine Derivatives

Introduction

Gian Marco Leali is a noted inventor based in Milan, Italy, known for his contributions to the field of pharmaceuticals. With a focus on developing innovative compounds, Leali holds two patents that showcase his expertise in creating new therapeutic solutions.

Latest Patents

Leali's latest patents revolve around phthalazine derivatives as phosphodiesterase 4 inhibitors. These innovative compounds include:

- 1-(3,5-dichloro-pyridin-4-ylmethyl)-6-methoxy-4-phenyl-phthalazine

- 4-(3,5-dichloro-pyridin-4-ylmethyl)-7-methoxy-1H-phthalazin-2-carboxylic acid methyl ester

- Benzyl-{3-{1-(3,5-dichloro-pyridin-4-ylmethyl)-6-methoxy-phthalazin-5-yl}-prop-2-ynyl}-methyl-amine

- 1-(3,5-dichloro-pyridin-4-ylmethyl)-6-methoxy-5-(5-morpholin-4-yl-pent-1-ynyl)-phthalazine dihydrochloride

- 3-{1-(3,5-dichloro-pyridin-4-ylmethyl)-6-methoxy-phthalazin-5-yl}-prop-2-yn-1-ol

- 1-(3,5-dichloro-pyridin-4-ylmethyl)-6-methoxy-4-morpholin-4-yl-phthalazine

- 1-(3,5-dichloro-pyridin-4-ylmethyl)-6-methoxy-4-(1,2,4)triazol-1-yl-phthalazine

- N→O derivatives thereof; and pharmaceutically acceptable salts thereof.

Moreover, his inventions include a pharmaceutical composition that contains a therapeutically effective amount of these compounds mixed with a suitable carrier.

Career Highlights

Leali is affiliated with Zambon Group S.p.A., a company renowned for its commitment to advancing health through innovative pharmaceuticals. His work within this esteemed organization underscores his dedication to research and development in medicinal chemistry.

Collaborations

Throughout his career, Gian Marco Leali has collaborated with talented professionals such as Mauro Napoletano and Gabriele Pietro Norcini. These partnerships have further enhanced his ability to innovate and develop cutting-edge solutions in pharmaceutical science.

Conclusion

Gian Marco Leali represents the spirit of innovation in the pharmaceutical field with his significant contributions to the development of phthalazine derivatives. His ongoing work at Zambon Group S.p.A. and collaborations with esteemed colleagues highlight the impact of teamwork in driving forward the boundaries of science and medicine. Through his patents, Leali not only advances therapeutic options but also enhances the potential for improved patient outcomes.